Clearstead Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.6K Sell
1,132
-958
-46% -$6.38K ﹤0.01% 1988
2026
Q1
$11.4K Hold
2,090
﹤0.01% 1559
2025
Q4
$14.6K Sell
2,090
-125
-6% -$979 ﹤0.01% 1799
2025
Q3
$17.1K Buy
2,215
+700
+46% +$5.46K ﹤0.01% 1713
2025
Q2
$13.2K Hold
1,515
﹤0.01% 1787
2025
Q1
$12.1K Hold
1,515
﹤0.01% 1562
2024
Q4
$13.8K Sell
1,515
-1,350
-47% -$13K ﹤0.01% 1496
2024
Q3
$26.3K Buy
2,865
+800
+39% +$6.62K ﹤0.01% 1353
2024
Q2
$20.2K Hold
2,065
﹤0.01% 1377
2024
Q1
$25.7K Buy
2,065
+1,425
+223% +$25.9K ﹤0.01% 900
2023
Q4
$13.8K Buy
640
+290
+83% +$5.35K ﹤0.01% 1003
2023
Q3
$6.51K Hold
350
﹤0.01% 1050
2023
Q2
$8.86K Buy
350
+200
+133% +$5.03K ﹤0.01% 999
2023
Q1
$3.88K Sell
150
-180
-55% -$4.82K ﹤0.01% 1049
2022
Q4
$7.8K Buy
330
+65
+25% +$1.75K ﹤0.01% 936
2022
Q3
$7K Sell
265
-335
-56% -$11.8K ﹤0.01% 941
2022
Q2
$20K Buy
600
+175
+41% +$7.43K ﹤0.01% 804
2022
Q1
$31K Buy
425
+150
+55% +$10.8K ﹤0.01% 775
2021
Q4
$25K Sell
275
-2,238
-89% -$267K ﹤0.01% 774
2021
Q3
$319K Buy
2,513
+2,380
+1,789% +$347K 0.02% 304
2021
Q2
$22K Hold
133
﹤0.01% 696
2021
Q1
$24K Hold
133
﹤0.01% 645
2020
Q4
$27K Buy
133
+3
+2% +$610 ﹤0.01% 588
2020
Q3
$29K Buy
130
+5
+4% +$1.06K ﹤0.01% 547
2020
Q2
$24K Hold
125
﹤0.01% 513
2020
Q1
$19K Buy
+125
New +$14.5K ﹤0.01% 510

Other funds holding TDOC

Clearstead Advisors's TDOC Position: Q2 2026 in Review

Clearstead Advisors reduced its Teladoc Health (TDOC) stake by 46% in Q2 2026, selling an estimated $6.38K and leaving 1,132 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Clearstead Advisors first reported a position in TDOC in Q1 2020 and has held it in 26 quarters since. The position peaked at $319K in Q3 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Clearstead Advisors held 1,132 shares of Teladoc Health worth $9.6K as of Q2 2026.
  • Clearstead Advisors sold 958 Teladoc Health shares in Q2 2026, an estimated $6.38K.
  • Teladoc Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1988 holding.
  • Clearstead Advisors first reported a position in Teladoc Health in Q1 2020 and has held it in 26 quarters since.
  • Clearstead Advisors's Teladoc Health position peaked at $319K in Q3 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.